
Picking the right benzodiazepine based on its metabolism is a critical concept for understanding medication safety, especially when considering hepatic function and drug accumulation. In this episode of This Is Why, Dr. Busti walks through a board-style practice question to break down how different metabolic pathways impact clinical decision-making.
This case highlights how pharmacokinetics directly influences patient outcomes and why recognizing metabolism patterns is essential for safe prescribing.
Topics Covered:
- Benzodiazepine metabolism overview
- Phase 1 vs phase 2 hepatic metabolism
- CYP450 oxidation and active metabolites
- Glucuronidation and drug clearance
- Pharmacokinetics in older adults
- Drug accumulation and prolonged effects
- Clinical decision-making in anxiolytic therapy
- High-yield pharmacology concepts for board preparation
The goal = make medical education easy and clinically relevant.
If this helped you, please like, subscribe to our YouTube Channel, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.
Don’t forget to turn on notifications on YouTube so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!
#benzodiazepinemetabolism #LOTdrugs #practicequestion #cyp450pharmacology #DrBusti
Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.
